Effects of Smoking on the Pharmacokinetics of Erlotinib
HAMILTON, Marta, WOLF, Julie L, RUSK, Jason, BEARD, Shannon E, CLARK, Gary M, WITT, Karsten, CAGNONI, Pablo J
Published in Clinical cancer research (01.04.2006)
Published in Clinical cancer research (01.04.2006)
Get full text
Journal Article
A Randomized, Phase II, Biomarker-Selected Study Comparing Erlotinib to Erlotinib Intercalated With Chemotherapy in First-Line Therapy for Advanced Non–Small-Cell Lung Cancer
HIRSCH, Fred R, KABBINAVAR, Fairooz, RUSK, Jason, FRANKLIN, Wilbur A, VARELLA-GARCIA, Marileila, BUNN, Paul A, ROSS CAMIDGE, D, EISEN, Tim, MARTINS, Renato, SCHNELL, Fredrick M, DZIADZIUSZKO, Rafal, RICHARDSON, Katherine, RICHARDSON, Frank, WACKER, Bret, STERNBERG, David W
Published in Journal of clinical oncology (10.09.2011)
Published in Journal of clinical oncology (10.09.2011)
Get full text
Journal Article
A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancer
Seiden, Michael V, Muggia, Franco, Astrow, Allan, Matulonis, Ursula, Campos, Susanna, Roche, Maria, Sivret, Julia, Rusk, Jason, Barrett, Emma
Published in Gynecologic oncology (01.04.2004)
Published in Gynecologic oncology (01.04.2004)
Get full text
Journal Article
Docetaxel and Exisulind in Previously Treated Non-small Cell Lung Cancer (NSCLC) Patients: A Multicenter, Phase II Clinical Trial
Weiss, Glen J., Vokes, Everett E., Bunn, Paul A., Magree, Lyn, Rusk, Jason, Albert, Don, Kelly, Karen
Published in Journal of thoracic oncology (01.10.2007)
Published in Journal of thoracic oncology (01.10.2007)
Get full text
Journal Article
Liposomal daunorubicin (DaunoXome) plus dexamethasone for patients with multiple myeloma
Mohrbacher, Ann F., Gregory, Stephanie A., Gabriel, Don A., Rusk, Jason M., Giles, Francis J.
Published in Cancer (15.05.2002)
Published in Cancer (15.05.2002)
Get full text
Journal Article